OptiBiotix Health (OPTI) was one of our tips of the year, with we anticipating financial progress as its deals for its compounds expand and further deals kick-in. It has now announced that a further human volunteer study on its cholesterol-reducing probiotic LPLDL - on a different population group of hypercholesterolemic adults – has shown “at six weeks, when volunteers taking placebo were compared to those taking LPLDL, there were statistically significant changes to clinically important cardiovascular risk”, including “34.2% reduction in total cholesterol (p=0.001)”.
I start with a few minutes on Woodlarks. This may be my last year doing the Rogue Bloggers Walk but myself, Lucian Miers, and Jonathan Price are minded to do it once more in May or June. On the basis that it could be a last hurrah and that you may want to consider a way of shifting that Christmas belly bulge how about you join us in 2022? Then onto Optibiotix (OPTI) where its NEDs have behaved in a most disgraceful way with free money share option troughing. As a loyal shareholder this is another kick in the gonads for me and I urge Steve O’Hara to sack three of the four of them and replace them with one new, less greedy, individual. Actually I’d go for all four booting out chairman Neil Davidson as well.
I finally got around to doing what was a New Year resolution of 2021 over Christmas. I discuss that, and then Optibiotix (OPTI) and Lombard Capital (LCAP) a posterboy for the Aquis shit-fest.
OptiBiotix Health (OPTI) has followed a sales agreement with Apollo Hospitals Enterprises for its GoFigure weight management product range in India with an agreement for GoFigure and SlimBiome Medical in Saudi Arabia (KSA). Is this further encouraging progress or just more flannel?
I start with a report on life at the only place in the world wetter than Wales. Will harvester B have to swim across the dry river to make it home? There are photos on my site but it is getting a bit nerve wracking. I look at crypto and answer questions from reader Guy as to whether it is a bubble. I discuss the ethics of Matt Earl closing most of his Civitas Social Housing (CSH) short and I admit again to being bored by Ariana (AAU) while others are bored by Optibiotix (OPTI) but is that a reason to sell?
OptiBiotix Health (OPTI) has announced the launch of a new sports nutrition product range, LeanBiome, with a supply & licensing agreement with “a leading global player in beauty & nutrition”. What of a current share price response up to 42.5p?
In today’s Bearcast I refer to my earlier podcast on the Botswana variant market sell off but take that forward to specific stocks to be buying and shares to be selling as a result. Then I look at Optbiotix (OPTI) and whether Steve O’Hara has been a naughty boy, ADM Energy (ADME) and my expose of earlier HERE – you ain’t seen nothing yet - and Union Jack Oil (UJO).
Having been falling from early this month, shares in SkinBioTherapeutics (SBTX) are currently further lower after it announced “OptiBiotix Health Plc has placed 3,636,363 ordinary shares in SkinBioTherapeutics with new and existing institutional investors at a price of 55 pence per share”. With SkinBioTherapeutics CEO Stuart Ashman though arguing “the company is going from strength to strength” and “it is important to attract new investors who are keen to come on board to support us in the next stage of the company’s development, as a commercial entity”, why the further share price fall?
I record from the Welsh Hovel which is once again a building site. Excuse any background noise. I look at Wildcat Petroleum (WCAT) and its uncorrected and untrue 4 October RNS. Then at the fraud Chill Brands (CHLL). In both cases the regulator, the hapless FCA, should be acting right now. Then it is onto Cineworld (CINE) and, with the graphic below – hat tip EB. I explain why its trading statement is so deceptive and why the shares are still a sell. Finally a few words on Optibiotix (OPTI) & Skinbiotherapeutics (SBTX) and today’s confirmation of what a good journalist I am. What does it mean for both stocks?
As predicted HERE the print going through late on Friday was Optibiotix (OPTI) dumping £2 million worth of Skinbiotherapeutics (SBTX) at 55p. I told you that this would happpen weeks ago producing more bluster and fake denials from all involved. Fuckers! The release this morning insults the intelligence of we loyal shareholders in both companies yet again. Stuart, Steve, posh PR bird Melanie Toyne-Sewell and the scumbags at Cenkos do you think we are idiots? You treat us as if we are.
I predicted that this was the plan and such a trade went through on the prints late on Friday. Both Optibiotix (OPTI) and Skinbiotherapeutics (SBTX) have declined chances I have offered ( two for Opti) to deny the trade was as I speculate. So where does this leave shareholders in both companies and the, badly advised by scumbags Cenkos, Steve O’Hara?
In today’s Bearcast, I look at Skinbiotherapeutics (SBTX), Optibiotix (OPTI), Kefi (KEFI), Nightcap (NGHT), VAST Resources (VAST) and finally at my old pal Richard Poulden’s Valereum Blockchain (VLRM), the current love interest of Big Dave Lenigas.
In today’s podcast I discuss Optibiotix (OPTI) and another battle from the ShareProphets comments boards. Then I look at Alien Metals (UFO) and Anglesy Mining (AYM), at Kanobo (KNB), Guild ESports (GILD) and at Reabold Resources (RBD). I start with a few words on last night’s video recording with the All Party Parliamentary Group on Personal Banking and Fairer Financial Services. With reference to it, if I sound conceited it is because, in my humble opinion, I have every right to be. The Alien expose to which I refer is HERE.
I have a few words on Malcolm’s article of earlier which, by definition, makes me old according to him. Pot. Kettle. I talk about the general mood of insanity. Then, in that context, I look at the Optibiotix (OPTI) vs Skinbiotherapeutics (SBTX) debate. Should one short one and go long the other as PL has suggested? I discuss what I am doing and why.
Life sciences compounds developer OptiBiotix Health (OPTI) has announced results for the first of calendar 2021, emphasising “sales of LPLDL and SlimBiome of £1.076m, a 44.5% increase over H1:2020… pleasing given the continued uncertain global economic environment and challenges of the subsequent waves of COVID-19, particularly in countries like India and the USA”. The shares have currently responded slightly higher, to 50p.
Today is not only Joshua’s Birthday but also 100 days to Christmas and also Dydd Owain Glyndwr Hapus!. So I am busy cake making. Maybe a picture later after I burn my own house down in honour of the last Welsh Prince of Wales. In the podcast I discuss naughty corporate brokers, Optibiotix (OPTI) and Novacyt (NCYT)
This event was held on 9 September and what follows is a transcript of the more interesting Q&As. There is oodles of jam tomorrow but I sense that the time for that working has passed. Steve O’Hara and Optibiotix (OPTI) need to start delivering jam today to drive a re-rate of any sort, let alone from £50 million to £1 billion as suggested in Q1.
I start with the Chris Cleverly West Ham round-up and what says about our attitude to white collar crime in the UK. What it says disgusts me. I move onto Optibiotix (OPTI). I am still a bull but i explian to the company why it is so unloved. Then finally to Cineworld (CINE) a slam dunk short at 63p. This could be a penny stock after an inevitable debt for equity swap but, taking a 30 year view, I would not buy even then.
Cenkos is house broker to Optibiotix (OPTI) so it is biased. I own a truck load of shares in Optibiotix so I am biased. But this 34 page note is detailed and may give you pause for thought. Steve O’Hara is doing an online presentation and Q&A tonight. I am not attending as I am washing my hair. Brokers notes and investor love-ins are all very well what I want to see now are material revenues and profits. And, while notes and presentations may tickle the share price, a material re-rate can only come from those sales and profits being delivered. I still believe that it will happen but I understand that others are bored of waiting. The full note is below.
OptiBiotix Health (OPTI) has announced further growth with an agreement to extend the territories of its deal with Seed Health.
OptiBiotix Health (OPTI) has made a “Trading and commercial update” including that sales are ahead of its expectations for the first six months of the year and that it “believes it is in a strong position to meet or exceed its full year sales forecast”. The shares have currently responded up to 49.5p but there looks much further to go.
I start with a discussion on the forest fires in this region of Greece then move onto the impending total humiliation of Julie “Lingerie on Expenses” Meyer after today’s shocker HERE. Then I look at Supply@ME Capital (SYME) asking if its boss owns any shares at all. He certainly does not own 26% as claimed. Then I look at the Optibiotix (OPTI) trading statement discussing it and Skinbiotherapeutics (SBTX). Finally back to a wretch: Versarien (VRS) and its shite results which show why we must get Ian Westbrook over the line – he is now, with a slightly extended deadline – just £1775 shy of making the loathsome Neill Ricketts sweat in court. Please keep giving those tenners and twenties HERE
I start with a defence of my share tipping on Optibiotix (OPTI). Am I really responsible for a chap who has bought and sold four times each time making a loss? He blames me. Then I consider if I should buy, sell or just hold MyHealthChecked (MHC). Then a few words on Father’s Day and also a few words on how I shall be annoying Abi the mutant curtain twitcher tomorrow.
OptiBiotix Health (OPTI) has announced its 2020 calendar year results, emphasising improving financials and that it is well placed to exploit a now established low overhead, sustainable business model. It is what we learned in a chat with Steve O’Hara that makes us flag this up as such a STRONG BUY.
I start with a morning spent cleaning up Joshua’s attic, a picture of which and of the Mrs looking stunning as she claims the credit is HERE. Then it is onto the fraud Supply@ME Capital (SYME), Bidstack (BIDS) and Optibiotix (OPTI).
SkinBioTherapeutics (SBTX) has announced the results of the AxisBiotix-PsT consumer study of patients suffering from psoriasis and it says that it will now be seeking regulatory approval for the product as a food supplement in parallel in the UK, US and Europe… targeting a commercial launch of theAxisBiotix-Ps™ product in Q4 2021”. Do the maths! This is going to be massive.
In today’s podcast, I cover Colin Bird’s latest pointless IPO, African Pioneer (ASP/AFP), Galileo Resources (GLR), Amigo (AMGO), Optibiotix (OPTI), Nightcap (NGHT), Catenae (CTEA), Powerhouse Energy (PHE), Sound Energy (SOU), the fraud Zoetic (ZOE), Harvest Minerals (HMI), and how proud I am of my garden.
Okay, tomorrow is the big day. If you are yet to donate please do so HERE as the Rogue Bloggers are now just over £2,000 off target. In today’s podcast, I discuss at length issues arising from the Skinbiotherapeutics (SBTX) and Optibiotix (OPTI) issue where Steve O’Hara says a man who took a company to the Isle of Man knows nothing about tax! Then onto the fraud Zoetic (ZOE), company specific issues and the wider one, raised by promoter David Lenigas today, of the increased risk caused by margin buying of small caps.
Two days to the Rogue Bloggers for Woodlarks walk and £2,500 needed. Please donate HERE. In today’s podcast I look at Optibiotix (OPTI), Bidstack (BIDS), Argo Blockchain (ARB) and day 2 of the Zoetic (ZOE) fraud not answering a simple but critical question.
The good news is that Rogue Bloggers for Woodlarks is, 3 days ahead of our walk, now less than £3,000 away from our £48,000 fund raise target. If you are yet to donate, please do so HERE. In today’s podcast, I discuss Amigo (AMGO), Wishbone Gold (WSBN), Zoetic (ZOE), Skinbiotherapeutics (SBTX) and Optibiotix (OPTI).
And now from Wales, by just 30 yards, it is my new weekly video show. This costs 99p per episode, and you can either listen to, or watch, some sparky interviews with Optibiotix (OPTI) boss Steve O’Hara and oil guru Peter Brailey. There is also me. I am a big investor in Optibiotix but explain why I am angry but not selling and challenge Peter on how to play oil plus he and I discuss the most overvalued stock on the Standard List, a total joke capitalised at almost £100 million, worth c£1 million.You can access the show HERE
My video with Optibiotix (OPTI) boss Steve is with Darren and the show should go live tomorrow. But I pick up on one point and that is the behaviour of IIs vs PIs. Then with that also in mind, I look at Savannah Resources (SAV), comment on Big Sofa (BST) and then on the fun and games at Versarien (VRS) which could well bring my 0p target a lot sooner than I had thought. We have now raised more than £15,000 ( with gift aid) as the rogue bloggers for Woodlarks. Thank you to Jocelyn and Vin for two big donations today, can you please also be generous and donate HERE.
Post your entries in the comments section below. The prize is a signed photo of Darren Atwater in his swimming trunks and the contest concerns UK Oil & Gas (UKOG) which I discuss. I also mention Optibiotix (OPTI) en passant, explain how a Supply@ME Capital (SYME) acquisition works and look at Trainline (TRN).
The 98% of you yet to donate to rogue bloggers for Woodlarks will not have seen the offer made by Optibiotix (OPTI) boss Steve O’Hara. You can both see his offer and make a donation as you think of the misery that looms for Andrew Bell on 29 May HERE. In the rest of the podcast I discuss being snitched on by some cottage burning freak, Ridgecrest (RDGC), Bluebird Merchant Ventures (BMV) and Alba Minerals (ALBA).
Quite honestly what is the point of announcing a lock in arrangement when across London’s junior markets folks either ignore them completely or sell a big line and then get everyone to agree that the lock in now only applies to the remaining shares? Why not be honest and say that what is in effect is an Orderly Market Arrangement except when folks just dump with no sanction which is a disorderly market arrangement?
I am in complete agony after a 20 mile training walk for Woodlarks. Feel my pain and please make a donation to rogue bloggers today. Then I make a few more observations about Optibiotix (OPTI) and its chairman.
I start with a few words on the late Phil the Greek and reference an article I wrote exactly one month ago HERE on the liberal US celeb Joy Behar calling out Phil and his family as Nazis. I reflect on the weather here in Wales and how tomorrow’s 20 mile training walk for Woodlarks will be very unpleasant indeed. So please do support me with a donation HERE. Then I discuss the saintly Vin Murria and share sales at Summerway (SWC) and for the first and last time in history I am a bit uneasy about all of this. Then the debate on whether to back the Skinbiotherapeutics (SBTX) or the Optibiotix (OPTI) charger?
I start with a true story. Surely it is a cracking warning of the top of the market. Then onto the fraud Supply@ME Capital (SYME) confirming my scoop. Finally a long discussion on the morality of breaking lock-ins ref Optibiotix (OPTI), Skinbiotherapeutics (SBTX) and Powerhouse Energy (PHE) run by sleazy ex Tory MP Tim Yeo.
Notwithstanding the lock-in shenanigans with Optibiotix (OPTI) discussed HERE, I am more bullish than ever. The results from Skinbiotherapeutics (SBTX) for the six months to 31 December 2020 came out on Monday. I apologise for the delayed update but I needed to ponder a while. What we read a few days ago was just excellent. Hence this upgrade.
Yesterday it was Skinbiotherapeutics (SBTX) which allowed Optibiotix (OPTI) to dump shares less than six months after announcing a firm lock in agreement lasting 12 months. Today it is Powerhouse Energy (PHE) showing that these announcements are utterly meaningless and investors cannot rely on them at all.
I think Optibiotix (OPTI) shares are very cheap as are those of Skinbiotherapeutics (SBTX) and am a loyal shareholder in both expecting to treble my money from here. Nor do I begrudge Optibiotix selling a few shares in Skinbiotherapeutics as it announced it had today as I imagine that will more than pay for a Nasdaq listing which may drive a re-rate. But I suggest that, in light of today’s events, a document signed by Steve O’Hara and Nomad and broker Cenkos is a worthless piece of toilet paper and both have legged over and deceived investors in Skinbiotherapeutics. Let me explain.
OptiBiotix Health (OPTI) has announced a “Commercial strategy update” which shows strong progress in its strategy to initially build sales and brand presence and then move up the value chain by selling more product than ingredients and commercialising further compounds. We’ve also had a catch up chat with CEO Steve O’Hara. This should be THE YEAR when profits come close to or exceed £1 million.
Don’t get me wrong, I like the Optibiotix (OPTI) meal substitute drinks and do actually feel better after just a few days of losing a meal a day and a week of near zero carbs and no booze at all. But a serving suggestion from one reader went down very badly. Elsewhere I look at Sabien Technology (SNT) and the fallout from l’affaire Julie Meyer, Skinbiotherapeutics (SBTX) and also at Provident Financial (PFG).
I start discussing my weight, as HERE, the annual Woodlarks walk and how my use of Optibiotix (OPTI) shakes is going. Then onto Sam Gyimah and the diversity in business myth. If you are listening in Scotland, do not discuss this podcast with your other half at supper tonight or else! Then onto today’s shocking news about Julie “Lingerie on Expenses” Meyer.
A chap says he has made five hundred grand on Eurasia (EUA) so what does it matter if a few rules have been broken? I explain exactly why it matters and should matter even to him. Then I address why shares in Optibiotix (OPTI) are not reacting to the surging share price of Skinbiotherapeutics (SBTX). Natch I remain a loyal shareholder in both.
A few words on the Budget then is Peterhouse staffed by woke loons or alt right freaks or both? I discuss in relation to Mountfield (MOGP). I look at Marchale (MAC), Iconic (ICON), Optibiotix (OPTI) and Skinbiotherapeutics (SBTX).
As a loyal shareholder I see nothing to shock me and a good bit to please. Specifically:
OptiBiotix Health (OPTI) has announced a trading update, emphasising “another year of progress… probiotic and functional fibre divisions achieving profitability”. The shares have though currently responded lower to 55.5p, so what’s the current situation here? We’ve spoken to Chief Executive Steve O’Hara and we believe that Mr Market has got this one wrong.
In today’s podcast I look at Remote Monitored Systems (RMS), Online Blockchain (OBC), Zoetic (ZOE), Zenith Energy (ZEN) - after today’s bombshell expose - ADVFN (AFN), Optibiotix (OPTI) and Skinbiotherapeutics (SBTX).
I am a massive shareholder in Optibiotix (OPTI) and believe that I will do very well from my investment, where my average in price is c9p. The shares are now 61.5p mid and I think they will easily double from here within 18 months if not far sooner. But there can be no double standards here in the way that I cover companies, just because I own shares in them. I think the company has made a material accounting error which is also an own goal! Here’s why:
Yup, if he does an interview with me and my tough questions, shares in Optibiotix (OPTI) go down. So, going forward, it is only those paid-for interviews with folks like Proactive. “Steve, is your schlonger enormous or gigantic? Why are your shares so cheap? etc etc.” Whatever, I apologise to you all for asking the odd question. Without my malign influence, Optibiotix would clearly be in the FTSE 100. I discuss this company’s prospects and also those of Skinbiotherapeutics (SBTX) where I am also a loyal shareholder. I look at Trainline (TRN), Online Blockchain (OBC) and Vast Resources (VAST).
I start with the non-financial GroupThink but explain how this is relevant to three shares: Remote Monitored Systems (RMS), Optibiotix (OPTI), and Cineworld (CINE). And I outline why two of the three are screaming sells and one a screaming buy. Guess which? I refer to this article I penned earlier on how dissent from GroupThink is being stifled.
Optibiotix (OPTI) has announced that Non Executive Director (NED) Peter Wennstrom – of whom we’d never heard – is to step down to be replaced by Christopher Brinsmead CBE, subject to the completion of regulatory due diligence being carried out by the Company’s Nomad. For a £50 million odd capitalised company, Brinsmead is a real BSD to pick up.
OptiBiotix Health (OPTI) has emphasised “another step in building brand and product presence in the large North American market” as it announced its latest deal. Yes it is a step but frustratingly one revealed on a release using the Adam Reynolds keyboard. The one with no numbers on it.
I have been chewing over what to do about my little stash of subscription shares for fully listed Golden Prospect (full shares: GPM, subs: GPSS) as the deadline for coughing up the subscription price is almost upon us. There are hard decisions to be made….
In today’s podcast I look at Cineworld (CINE), Trainline (TRN), Novacyt (NCYT), Powerhouse Energy (PHE), Optibiotix (OPTI) and Skinbiotherapeutics (SBTX).
And so we are indeed heading back into lockdown. I’ll leave aside the merits or otherwise of that, but would urge readers to take a look at THIS and consider a polite, brief but acid note to your MP pointing out that their own job prospects may be in question if they do not challenge Bonkers Boris, as suggested by Peter Hitchens if you think fit. The question now, for investors, is what to do.
I am back here at last and allow a bit of time for personal matters. Then it is on to Optibiotix (OPTI), Skinbiotherapeutics (SBTX), Verditek (VDTK) and G3 Exploration (G3E)
OptiBiotix Health (OPTI) “announces the launch of meal replacement shakes and bars containing OptiBiotix’s OptiBiome® proprietary weight management technology under the Optislim® brand with Woolworths, Chemist Warehouse and on OptiPharm Pty Ltd’s online store in Australia and New Zealand”…
OptiBiotix Health (OPTI) is “pleased to have signed an agreement with UITC to distribute CholBiomeX3 in Singapore”…
I have a small holding in AIM-listed Optibiotix (OPTI) – perhaps Tom Winnifrith’s favourite stock. It has been a wild ride, with the shares having headed above £1 a pop but the stock has certainly been in the doldrums recently, having tested 50p over the summer and has now perked up to just 63p. Yet we are getting an extended flurry of contracts and deals which should transform this business, which as far as I can see has little issue over cash whilst we await the mega-profits promised. What gives?…
OptiBiotix Health (OPTI) is “pleased to see that Seed has achieved FDA authorisation for an IND in a product containing OptiBiotix’s Lactobacillus plantarum LPLDL®”. So, what does this mean?…
OptiBiotix (OPTI) has announced that it is “pleased to have signed an agreement with UITC to distribute our award-winning medical device in Singapore”…
OptiBiotix Health (OPTI) is “pleased to present… results for the six month period ended 30 June 2020” and we have had a chat with CEO Steve O’Hara…
OptiBiotix Health (OPTI) is “pleased to announce… an exclusive distribution agreement with Ayalla Marketing for the distribution of its cholesterol reducing probiotic, LPLDL®, as an ingredient and as four finished products (CholBiome, CholBiomeX3, CholBiomeBP and CholBiomeVH) within the CholBiome® portfolio for Brazil”…
OptiBiotix Health (OPTI) is “pleased to announce that it has has entered into an agreement with a US company for the purpose of large scale manufacture and commercialisation of a number of SweetBiotix® products”…
I have been doing good work on the mystery of who my great grandmother really was. My great aunt, her daughter being the actress Anna Lee, did some work as you can see HERE, but I have gone a step further and have an agreement to do a DNA test to solve the mystery once and for all. I discuss this distraction and then move on to Sound Energy (SOU), Optibiotix (OPTI), Cobra Resources (COBR), and 7 Digital (7DIG).
OptiBiotix Health (OPTI) has recently been “pleased to announce the extension of terms for CTC. This agreement recognises CTC's success in building sales of SlimBiome® and extends terms to enhance further sales growth, supported by minimum sales targets. This is a first commercial step in bringing our new functional ingredient WellBiome® to global markets and building brand awareness” and “pleased to announce… a second commercial step in bringing OptiBiotix's new functional ingredient WellBiome® to global markets and building brand awareness”...
I start with why I am so sceptical, even cross about Rishi Sunak's mini budget yesterday. Some measures are profilgate, others downright counter productive. Then it is onto Eurasia (EUR) and the red flags that make be sceptical although I would be happy, for him at least, if my pal Christian got rich. Then onto Kefi (KEFI) and another gold stock I own and why they could really rip higher on a three month view. Finally I answer a reader question about Optibiotix (OPTI). No my faith is not waning at all. Au contraire, after a company chat earlier....
More news from OptiBiotix Health (OPTI) and we’re also asked to clarify re. previous statements by the company...
I start with my training walk of yesterday for rogue bloggers for Woodlarks. i managed 12.5 laps before the sun got to me. In two weeks I must do 50. My next big walk is Tuesday - we are at 36% of target so please do donate HERE. Next up in hargreaves Lansdown (HL.), why not screw your customers as they seem to like it? Then onto share sales in Skinbiotherapeutics (SBTX) by Optibiotix (OPTI) and what appears to be a scandal involving broker SP Angel. I shall be going to the FCA tomorrow to ask for an enquiry. Finally is Steve O'Hara a liar like Lyin' James Draper of Bidstack (BIDS). Drunken Sailor who is suffering a GroupThink induced lockdown dementia thinks so and also that I am a ramper and should tell folks to sell. I discuss Drunken's concerns in light of a chat with O'Hara and an email from him which I read out.
Currently compounds to tackle obesity, high cholesterol and diabetes developer, OptiBiotix Health (OPTI) has announced results for the 13 months to 31st December 2019 (having moved its year-end from November), emphasising it “has met a significant number of important objectives that continue to build value for shareholders”. The shares have currently responded a bit lower to 62p, but the numbers are historic and look at the trading trajectory now...
Updating on OptiBiotix Health (OPTI) earlier this week we noted interest from larger partners and shorter partner discussions as sales are significantly developing. Now “a non-exclusive license agreement for its SlimBiome® trademark with Evolution_18 and related launch of fibre gummies containing OptiBiotix's SlimBiome® proprietary weight management technology”…
OptiBiotix Health (OPTI) has updated including noting first quarter of 2020 sales of £407,844 – and the shares have responded 11% higher to above 60p. Capitalising the company at around £53 million, why you may ask? Well, look at the company’s trajectory...
Malcolm will not approve of this as he regards it as unethical. But I am getting older and, to date, Centamin (CEY) and San Leon (SLE) are the only dividend paying stocks in my pension. And that has to change
OptiBiotix Health (OPTI) has announced it’s “pleased to have signed an agreement… to commercialise our award-winning weight management technology in Taiwan”…
OptiBiotix Health (OPTI) has announced “a non-exclusive license agreement for its SlimBiome® trademark with Smart For Life, Inc. and related launch of cookies containing OptiBiotix's SlimBiome® proprietary weight management technology in the USA and Canada”...
Having asked for readers tips for 2020 for the prize of 1/2 litre of Tom Winnifrith's Greek Hovel olive oil (2020 harvest) HERE, the following is an update on performance at the end of April (to be eligible needed to have selected, on a per username basis, a buy & sell pick from the LSE or AIM casino and the stocks not to have been suspended at the commencement of 2020)...
Of course, those who know best will insist that this in no way validates the IP of Optibiotix (OPTI) and is a small deal which will not generate any license (and thus almost all margin with no working capital needed) profits at all. Whatever… So why has it not been announced?
A “Placing and Related Party Transaction” announcement from OptiBiotix Health (OPTI)… but we previously stated confidence of the company now moving to profitability, so are we wrong? No! In fact we are now far more bullish than ever before following a chat with boss Steve O'Hara earlier.
I start with a note on Bidstack (BIDS), which I shall be taking up with AIM Regulation over the weekend and end with Future (FUTR) which needs to issue a profits warning. In the middle I go therough the very murky tale at AIM listed All Active Asset (AAA) which sees uber ramper Chris Akers in action and Peterhouse Corporate Finance boss Peter Greensmith make a £768,000 killing in his private vehicles while acting as broker and pulling the strings at AAA and also acting as broker to suspended AIM stock Asimilar which is involved in this strange tangle. Then it is onto Optibiotix (OPTI) and a small placing. But this is not a bailout as Cynical will no doubt claim but,possibly a gateway, to a mega re-rate as I explain.
It looks like the cash that I did not realise until a few months ago I had, will finally arrive in my SIPP this week. so where will I invest it? I discuss my outlook for equities in general, what I shall avoid and then Optibiotix (OPTI). R4E (R4E), Imperial Brands (IMB), Centamin (CEY), Tesco (TSCO), BP (BP.), Shell (RDSB), Wishbone Gold (WSBN) Red Rock (RRR) and Fox Marble (FOX).
Last week we noted a “key” SlimBiome contract manufacturing agreement for OptiBiotix Health (OPTI)... now it “builds on” this such agreement for meal replacement shakes designed specifically to support the international expansion of its own label GoFigure® consumer weight management brand…
OptiBiotix Health (OPTI) has followed an “Exclusive licence agreement for OptiBiome®” with a contract manufacturing agreement for SlimBiome® with Fipros A/S, emphasising “the agreement is key”…
Natch I wish the Prime Minister a speedy recovery from Covid 19. I am sure that like almost all healthy victims he will recover and refer you to my two podcasts HERE and HERE as to why the Doomsayers are engaing in GroupThink but really cannot have it both ways: the virus cannot be both highly contagious and highly lethal. I discuss why the three day shares rally, now reversed today, cannot be justified in terms of the likely curve of corporate earnings recovery. I look at Next (NXT), Optibiotix (OPTI) and dual listings, Dev Clever (DEV) & Royal Mail Group (RMG)
A “Change of accounting year end” announcement from OptiBiotix Health (OPTI). But isn’t that a move of fraudsters or incompetents? Not in this case…
The prices of all AIM stocks are now essentially a binary bet. They are either 100% overvalued as they will go bust or, having collapsed, are fundamentally incredibly cheap as they are not going bust whatever the share price says. Optibiotix (OPTI) is very much in the latter category. I accept folks are panicking generally or they are facing margin calls elsewhere and have to sell shares to meet them. That however is not what will drive the share price in the long run...
It is a happy game which I have discussed with a couple of listeners. Anyhow, it just shows how data can be interpreted in so many ways. I am, you may be pleased, or maybe distressed, to hear taking steps tpo improve my chances. I then discuss the market crash and how it affects different classes of shares - the issue for us all is not whether our investments are cheap but will the equity in them survive? If the answer is YES then I suspect they are now cheap. If NO well then they are still expensive. I discuss Optibiotix (OPTI), Bidstack (BIDS), Versarien (VRS), Big Sofa (BST), Big Dish (DISH), Restaurant Group (RTN), Ascent Resources (AST), City Centre Pubs (CTC) and also why gold and gold shares are not soaring. Fear not, Malcolm Burne has the experience and the answer. They will.
I have communicated with Steve O Hara. The share price of Optibiotix (OPTI) is 34p and that is freaking some folks out. The share price does not reflect what is going on. I think a formal trading statement would be useful.
Don't worry the sun will still rise tomorrow and we are not ALL going to die of Coronavirus. I discuss the oil price crash and stockmarket slump and look in particular at: Tern (TERN), Carnival (CCL), Bidstack (BIDS), Versarien (VRS), the antics of market makers, Diversified Gas & Oil (DGOC), Bahamas Petroleum (BPC), BP (BP.), Shell (RDSB), Tullow (TLW), Optibiotix (OPTI) and Premier Oil (PMO)
OptiBiotix Health (OPTI) has updated on a number of developments CEO Steve O'Hara emphasises “support the commercialisation of its ingredients and products”…
Last week we noted a licencing agreement for LPLDL, of OptiBiotix Health (OPTI), was clearly positive with the potential then significantly added to but that Uruguay itself is clearly not the largest of markets. The latter is not the case for the United States and Canada!…
This really is today's bearcast despite my introduction. Thanks for the kind messages about the flooding, the waters are now recedng fast. In today's podcast I look at China and the Coronavirus and ask WHEN IQE (OQE) will warn and if that will force a discounted placing. Methinks it will. I then look at the rioles of brokers (does research mean anything)? and Nomads (rules on quitting) in general and specifically in relation to Versarien (FRAUD). Then I discussa crazed TW hater and Optibiotix (OPTI) and how ultimately all comment on a company cannot determine its real value. In that vein I also look at Novacyt (NCYT) before finally looking at the worthless joke that is Conroy Gold and Natural Resources (CGNR). And I announce a fifth rogue blogger, Praise the Lord. Please donate something to the Woodlarks appeal HERE
In today's podcast I discuss Carnival (CCL) and the Coronavirus, Optibiotix (OPTI) and Versarien (VRS)
OptiBiotix Health (OPTI) has announced “a significant milestone” in extension of the use of its LPLDL probiotic strain into functional foods and its presence into South America. So what you say?...
Tom Winnifrith writes: Two days ago on this very website I gave four reasons why I have never been so bullish about Optiubiotix (OPTI) with the shares then at a 60p offer. Now the offer is 67p and the shares are still a massive buy at up to 80p with a target to top slice at 125p achievable within months.
I start with a few words on Brexit Day and how we celebrated it HERE in Wales. Then with case studies Toople (TOOP) and Haydale (HAYD) I look at clear Nomad and adviser failings harking back to those at African Potash (AFPO) and suggesting why it is vital that, now, heads start to roll. I also discuss Future (FUTR) and Optibiotix (OPTI) and suggest that you all follow the great example of No Gold HERE
In today's podcast I discuss freedom of expression with reference to Alistair Stewart, Andrew Monk, Schroders and a whore's drawers. I look at ValiRx (VAL), the joke that is NEX Exchange Regulation, Oracle Power (ORCP), Andalas Energy (ADL) and Haydale Graphene (HAYD). Finally I defend No Gold ( please donate to the Rogue Bloggers for Woodlarks old chap, HERE) and report back on my Optibiotix (OPTI), Slimbiome weight loss programme.
I am now a customer as well as a shareholder having ordered two boxes of Slimbiome to help me shift, ahem, a few pounds. I shall report back on my progress. But you want to gain pounds don’t you? Well at a 60p offer, the way to do that is to buy more Optibiotix (OPTI) shares. I have as I have never been more confident about the company and its prospects. Let me explain why with reference to the four bits of news out this week...
The photos below show the two boxes of Slimbiome that arrived today at the Welsh Hovel and also one of the sachets, 21 of which sit in each box. I have used a standard loo roll in the pictures to give you an indication of size.
In today's podcast I discuss Optibiotix (OPTI), how the critics have moved the goalposts and the ghastly Daily Mail. I also look at Big Dish (DISH) where ennui is setting in, at misleading interims from the worthless cur that is Plutus Powergen (PPG), at serial confetti issuer Zenith Energy (ZEN) and then at Eurasia Mining (EUA) where, after this post, I should say Optiva is now denying it is doing a placing. But frankly, it's still a matter of when not if.
In short no, although this virus could well be far larger than some folks (Lucian) think. Elsewhere I discuss useless research from broker Goetz and Optibiotix (OPTI), Future (FUTR), Amigo (AMGO), Iconic (ICON), Oracle (ORCP) and Petra Diamonds (PDL)
My training for the Woodlarks 34 mile walk is going okay. This weekend I will do eight miles up and down Moel Famau twice. Come on: start sponsoring me please HERE. But, as Brokerman Dan kindly points out, the walk would be easier for me if I was not carrying two or three stone of surplus fat along with me. He is, I fear, for once, correct. So …
In today's photo bearcast I discuss ADVFN (AFN) and London's worst and fattest Nomad, Optibiotix (OPTI), Plutus Powergen (PPG), Dods (DODS), Tissue Regenix (TRX) and Sosandar (SOS) whose antics are enough to turn a man to drink.
If a trading statement needs explaining then it is badly written. Yet again Optibiotix (OPTI) stands accused of that. I really think the company should fire its PR PDQ. Frankly I could, and would, do a better job. As a result of a badly written release, folks are accusing boss Steve O’Hara of lying. He has not. Amid the confusion the shares have slipped to 50-52p. I have taken the chance to buy some more...
I clarify my share purchase ion Otibiotix (OPT). I discuss the revelations yesterday about the breakdown of historic income at Versarien (VRS) explaining, to BBMs who claim it does not, exactly why it does matter! Then I discuss whether Terry Smith's golden run is about to break badly for him. Do not get me wrong, I think Smith is an absolute top banana but I have a doubt or two.
The resignation letter from a NED at an AIM listed company is a shocker. So far there has been no RNS. If the company does not come clean on what is in the letter I shall publish in full on Monday as it opens up a serioes of cans of worms which raises far bigger scandals I suspect. I discus this at length. I also look at Plutus Powergen (PG), Zinc Media (ZIN) and in great detail Optibiotix (OPTI) where the professional cynics have got it wrong and need to apologise. I have bought more shares on the back of today's interims and explain why.
OptiBiotix Health (OPTI) has announced a first agreement with a major retailer for its SlimBiome® functional ingredient with a product range to be initially sold in the UK, Republic of Ireland, Netherlands, Belgium and Sweden by health food chain Holland & Barrett…
In today's podcast I look at mini-bond scandal house Wellesley Finance and why it once again shames new Bank of England Governor Andrew "asleep at the wheel" bailey and the shitheads round at the FCA. I comment on another of its failings in light of today's Neil Woodford News. I comment on Big Dish (DISH), have a theory about Angloa African Oil & Gas (AAOG), comment on Optibiotix (OPTI), Versarien (VRS) and ask how long its Nomad will tolerate Neill Ricketts and finally on Aston Martin Lagonda (AML).
I start with a service announcement. Then I look at Anglo African Oil & Gas (AAOG), Optibiotix (OPTI) and then I discuss Christmas, retail trends and macro trends. Though he arrives by the wrong route, Malcolm arrives at the right destination on this matter.
The screenshot below looks to be self explanatory. 715 UK stores. Ching. Ching. As I noted in bearcasts for most of the pre-Christmas week, Optibiotox (OPTI) shares are a strong buy. Might the company possibly RNS this?
I start where I finished yesterday with Optibiotix (OPTI). Then I look at Bidstack (BIDS), Dev Clever (DEV), Versarien (VRS), Infrastrata (INFA) and NMC Health (NMC)
Don't get me wrong, what Steve O' Hara said in an interview with Proactive today is great news for Optibiotix (OPTI), truly great news which makes the shares a compelling buy, but surely this is the stuff for an RNS? Surely it is price sensitive?
A day of triumph at the Welsh Hovel sees me discuss Sound Energy (SOU) whose hand I forced last night with this article, Bidstack (BIDS) which has finally come, partially, clean about the mess it is in and Iconic (ICON) which has yet to 'fess up to its woes but will do so soon. I also discuss one very good company, Optibiotix (OPTI)
OptiBiotix Health (OPTI) is “very pleased to have been granted a medical device status and a CE mark for the second time over a 12-month period”...
In today's podcast I look at two utterly absurd proposals from Labour on broadband and on Inheritance Tax. Insanity. I also warn No Gold that he better get his £50 ready for me on December 13. Then I look at Angus Energy (ANGS), Optibiotix (OPTI), Neil Woodford disasters Kier (KIE), Eddie Stobart Logistics (ESL) and Non-Standard Finance (NSF). Then at Veltyco (VLTY) which is clearly insolvent. 95p to 1.5p in two years, thank God it had a female CEO to demonstrate the benefits of boardroom diversity for some of that period. Incidentally that CEO Ms. Blau earned 220,000 Euro for just seven months work so did a great job of closing the #GenderPayGap. Rejoice! Rejoice!
Do not get me wrong. I am a big fan of Steve O’Hara. I think he is doing a cracking job at Optibiotix (OPTI) where – as a loyal and very material (for me) shareholder – I expect to see the shares more than double from 62p within the next year. However, I’d be a hypocrite if I did not hold O’Hara to the same standards as obvious scallywags like Neill Ricketts of Versarien (VRS) when it came to the disclosure of material information.
It has been announced OptiBiotix Health (OPTI) has sold 2.2 million further shares in 2017 spun-off onto AIM SkinBioTherapeutics (SBTX). This despite OptiBiotix’s results earlier this year including “SkinBiotherapeutics plc is making solid progress… As its partnership discussions turn into commercial agreements providing industry validation of its technology we anticipate SkinBiotherapeutics plc will grow in value, whereupon OptiBiotix shareholders will benefit from the appreciation of this asset”. So why the further sale?...
Yes Neil, I will be the guy turning up at some point today in a blue van at your luxury HQ to take some photos and maybe shoot a short video. My pal Nigel Somerville may be coming too. It will be good to catch up. See you later! In the podcast today I also look at Woodford Patient Capital Trust (WPCT), backing Richard Jennings at Global Resources Investment Trust (GRIT) and at Optibiotix (OPTI). I also receive complaints about my coverage of Neil yesterday. I despair.
OptiBiotix Health (OPTI) has updated investors with news including “completing Pharmaceutical GMP process validation and receiving the GRAS notification letter from the US FDA is a significant achievement for ProBiotix and LPLDL®. Few marketed probiotics have achieved this level of proven safety and efficacy and it has triggered another milestone payment in the US Pharmaceutical agreement”…
There are two guests in this week's show, First up I discuss recent events at Bahamas Petroleum (BPC). then I discuss sexism in the City and Big Sofa (BST) with its boss Kirsty Fuller. Then it is on to Adam Reynolds where we cover Sosandar (SOS), Optibiotix (OPTI), Big Sofa (BST), Yourgene (YGEN) and Concepta (CPT). It is during this segment that the cat and the rat feature. If you like this and can't wait seven days for more of the same you should listen to my Bearcast every day.
A “GoFigure agreement for Southern Africa” announcement from OptiBiotix Health(OPTI) Does this matter? Yes it all helps.
In this seventh edition of the ShareProphets Radio podcast sponsored by Turner Pope, this week, in order I discuss why Burford scrutiny is so welcome then interview Matt Earl, the Dark Destroyer, on Avanti (AVN) , Burford (BUR), IQE (IQE), First Derivatives (FDP), Versarien (VRS), Quindell (QPP)) and Kerry Group. After a few more thoughts from me on scrutiny of smaller AIM stocks I interview Steve O'Hara of Optibiotix (OPTI) and then discuss one area where I disagree with him on strategy. If you like this and can't wait seven days for more of the same you should listen to my Bearcast every day.
Shares in Optibiotix (OPTI) have fallen by more than a quarter on the back on results for the six months to May 31 which are, let us not kid ourselves, really not very impressive indeed. The bears are cock-a-hoop but now talking errant nonsense. We bulls look a bit daft. As a shareholder I feel a bit sore but, having chatted to CEO Steve O’Hara at length, I retain a stance of strong buy. I see one director, Fred Narbel, has bought 17,000 shares at 50p and I expect more, larger scale, boardroom buying to follow. And this is why...
Apologies for the background noise in the Thomas Cook (TCG) segment, a workman at the Welsh Hovel has not quite understood how I have to pay his bloated fucking wages. I also discuss Rutherford (RUTH)_and how it will destroy the reputation of Neil Woodford but not in the way Nigel suggests and Optibiotix (OPTI)
OptiBiotix Health (OPTI) is pleased to announce an exclusive manufacturing, supply and distribution agreement for its SlimBiome weight management technology in Australia and New Zealand…
I reflect on two sorts of fraudsters in the news, King conman Rob Terry HERE and chaps at Goals Soccer Centres (GOAL) HERE. I offer a cameo of life here in Greece explaining why the economy is such a joke, discuss Versarien (VRS) its latest news, the kiss of death from Zak Mir HERE, and its valuation and also comment on Optibiotix (OPTI) and the demise of the spivs at SVS Securities
On today's podcast I discuss Westminster Group (WSG) run by ex Tory MP Tony Baldry of 3DM infamy, Metro Bank (MTRO), the Sith Lord Zak Mir, Sam Antar, Optibiotix (OPTI), Inspirit (INSP) and Dev Clever (DEV) - when are its (sure to be dire) results?
Excuse my croaky voice. In this inaugural edition of the ShareProphets Radio podcast sponsored by Riverfort Global Capital, this week, in order I discuss the pot bubble, interview Nigel Somerville on Neil Woodford, flag up my next 3 FRC PLC victims, interview outspoken broker Andrew Monk, discuss why CSR is a waste of cash and interview Steve O'Hara of Optibiotix (OPTI). Enjoy. If you like this and can't wait seven days for more of the same you should listen to my Bearcast every day.
Optibiotix (OPTI) shares now trade at 72p to buy after the announcement of a new deal with a company called BioEnergiser Ltd for the online distribution of SlimBiome Medical in the UK. SlimBiome Medical is a CE-marked medical device which independent clinical studies show reduces hunger, cravings for sweet and savoury foods, and fat intake. Steve O’Hara tells me this is not because Optibiotix's own online sales are slowing. Far from it. But this is just another channel to market...
An update from OptiBiotix Health (OPTI); “Scientific and commercial update”...
In today's bearcast I look at Anglo African Oil & Gas (AAOG), Management Resource Solutions (MRS), the syphillitic welfare funded client of Cupid (CUP), Albert Technologies (ALB), Optibiotix (OPTI) and Dev Clever (DEV).
OptiBiotix (OPTI) has announced another license agreement to we loyal shareholders. This one is for the use of its ProBiotix’s LPLDL ingredient in cardiovascular food supplements in Japan and is set to mean a first LPLDL finished product placement on the Japanese market…
I have known that this move was in the offing for a couple of months. Quite simply the official broker to Optibiotix (OPTI), that is to say finnCap, is useless. But an AIM company needs a retained broker so it stays in place. However it is not publishing research nor is it putting forecasts into the market nor is it getting secondary buying of the stock by institutional investors. Finncap is FinnCrap...
In today's bearcast I touch on Neil Woodford and the duffing up he is getting today from Andrew Bailey head of the chocolate teapots at the FCA. Then I comment on Optibiotix (OPTI), RedT Energy (RED), Remote Monitoring Solutions (RMS)_ - formerly the criminal dog Strat Aero - RM2 (RM2) and Arden Partners (ARDN)
Optibiotix (OPTI) has announced what could be its biggest supply and manufacturing deal to date and it could be generating revenues within a couple of months. This is big, very big and at 80p offer the shares are a strong buy...
In this bearcast I ask a series of questions for PR spinners for Woodford Patient Capital Trust (WPCT). References to 210p should be 227p. Let's see what answers I get. I also look at Optibiotix (OPTI), RM2 (RM2), Mysale (MYSL), Agronomics (ANIC) and have a big question for Neill Ricketts and Versarien (VRS)
More positive news from OptiBiotix Health (OPTI)?... The company has announced an exclusive license agreement for the commercialisation of, currently fully-owned subsidiary, ProBiotix's cholesterol management products CholBiome and CholBiomex3 in Vietnam…
More positive news for us loyal OptiBiotix Health (OPTI) shareholders, with an announcement of “Appointment of CEO of ProBiotix Health”…
The shares are off a tad thanks to another piss poor hatchet piece on Stockopedia, which I take apart HERE. There is actually some good news from Optibiotix (OPTI)...
Broker Optiva has made a very generous donation to Rogue Bloggers for Woodlarks. Given how beastly I am about it (as is Levi) that is very generous. I suggest you follow suit HERE. Stockopedia has done another poor hatchet job on Optibiotix (OPTI). I explain why it is just a piss poor and pointless piece. The shares, at 89p are a BUY at up to 90p and will be 125p+ in a very short order.
Last week it was a Thai deal from OptiBiotix Health (OPTI), now there’s another for the European market...
Steve O’ Hara says he is looking to do two new distribution deals a month and so here is the first for May. Optibiotix (OPTI) has announced that its fully-owned subsidiary ProBiotix Health Ltd., has signed a license agreement with Instituto Español de Nutrición Personalizada, S.A. for the use of Lactobacillus plantarum (LPLDL) in personalised food supplements in Spain...
I start with missing cat news - it is mixed. Then I look at Optibiotix (OPTI) answering reader questions on gross margins, Management Resource Solutions (MRS), Bidstack (BIDS) Metro Bank (MTRO), BCA Marketplace (BCA), Alien Metals (UFO), Bould Opportunities (BOU), and an apology on Woodford Patient Capital Trust (WPCT). Now, to the 80% of Bearcast listeners yet to do the decent thing, please donate HERE. We are now at 38% of our target so all donations welcome as young Steve Moore says he may join the rogue bloggers.
The shares are down on the day by a couple of pence at 72p-75p. The press release was long, verbose and not well crafted. As a loyal shareholder, I found a long chat with boss Steve O’Hara far more constructive. Optibiotix (OPTI) has never been in a better place and thus its shares are very cheap and a strong buy...
I should say that the old rogue has been most helpful in starting to bring the Welsh Hovel back to life and I relay a take from Sunday. Inn just 26 days time he and I will be on the rogue bloggers for Woodlarks trek and, at the risk of repeating myself, to the 85% of bearcast listeners yet to donate, I WANT YOUR MONEY NOW!!! I gather Dan used to use that phrase quitye a bit in a professional capacity in days gone by. Anyhow please donate HERE. In the podcast I discuss Alien Metals (UFO), TrakM8 (TRAK), Optibiotix (OPTI), Yourgene (YGEN) and the scandal that is Ferro-Alloy Resources (FAR).
In today's bearcast I cover Optibiotix (OPTI), Vela (VELA), Woodford Patient Capital trust (WPCT), Ascent Resources (AST), Mosman Oil & Gas (MSMN), Management Resource Solutions (MRS), Bidstack (BIDS) and Optiva/Novum and a hot City rumour. Also I have a message for 90% of listeners - please be a hero today, my 21 mile training walk for this weekend has been planned so donate to Rogue Bloggers for Woodlarks HERE
Optibiotix (OPTI) has announced the launch of SlimBiome® Medical in the UK – as of 29 April. All; well and good and I remain an enthusiast for the shares - they are cheap. But there is another matter which is not so impressive in a word where transparency is now universally viewed as critical.
It is another piece in the jigsaw and it could turn out to be quite a large one. Optibiotix (OPTI) has announced that it has received a licence from the Food Standards and Safety Authority India (FSSAI) for its weight management product, SlimBiome to be manufactured in India. The approval was gained by Optibiotix's manufacturing partner, Zeon Life Sciences, for both SlimBiome and SlimBiome-containing products...
In this podcast I look at the growing mini bond scandal as I flag up another ponzi waiting to collapse today HERE. Then I do a review of my own bull portfolio: Optibiotix (OPTI), Yourgene (YGEN), Concepta (CPT), Big Sofa (BST), Wishbone (WSBN), Kefi (KEFI), Reach4Entertainment (R4E), Falanx (FLX), Fox Marble (FOX), Berkeley Energia (BKY) and Argo Blockchain (ARB). I did not mention Fox in the podcast so I'll do a seperate update later. Finally: why have you not joined the roll call of heros HERE? I say a few extra fucktards on that count.
Another day, another deal. Is this No. 30 or 31, I rather lose count. But if you watched the interview with Steve O’Hara the other day, HERE, you will know that the majority of those already signed are now generating revenues and the curve in nearly all of those is sharply upwards. Optibiotix (OPTI) is profitable and hugely operationally geared...
It is a Proactive interview so the questions are not exactly taxing. But the ansswers given by Steve O'Hara of Optibiotix (OPTI) are illuminating. "The majority" of partners are now generating revenues. This company has signed almost 30 deals. That tells me that the massive ramp up in sales in H2 of last year will continue and indeed accelerate in H1 this year and beyond so full steam ahead. I reckon the shares are a buy at the current 84p and at up to 90p and see the shares motoring ahead to 125p+ in short order. Note what O'Hara says about the pipeline of announcements.
Another day and another small piece of what will be an enormous jigsaw falls into place.
In today's bearcast I discuss I3 Energy (I3E), Redde (REDD) and hapless Neil Woodford, Concepta (CPT), Optibiotix (OPTI), Yourgene (YGEN), Big Sofa (BST), Mirriad (MIRI) and Mothercare (MTC). If you enjoyed this, less than PC, bearcast, follow Jim Mellon and support the Rogue Bloggers for Woodlarks HERE.
My attention is drawn to a press release issued by this wretched Government which should, I believe, force Optibiotix (OPTI) to make a statement and make even the most cynical of bears wake up. It reads:
The market does not seem to have picked up on the significance of the most recent news from Optibiotix (OPTI). It will.
These days Optibiotix (OPTI) is on the cusp of being or already profitable and as such what excites us are rapidly growing revenues and new sales and marketing agreements. We will not have to wait long at all for more news on both those fronts. But behind this great company is the IP, the science.
In today's podcast I discuss Lonmin (LMI) but more importantly why I'd not invest in any South Africa based company, Purplebricks (PURP), Telit (TCM), Dev Clever (DEV) and Optibiotix (OPTI).
Thirsty Paul Scott was so flamed by some of his readers for his hatchet job on Optibiotix (OPTI) , littered, as it was, with false statements that he announced he would not be penning a column on Friday as he was, alongside thousands of school kids worried about global warming, going on strike. The difference between those withdrawing their labour on Friday is that the kids will, one day, grow up and most of the teenagers already produce work that is far less error strewn than that of the Thirsty one.
I report to you from the Grim North, a phrase Joshua has learned, much to the annoyance of the Mrs who is, herself, from the great post industrial welfare safari. In this podcast I cover Argo Blockchain (ARB), Optibiotiox (OPTI), Plus 500 (PLUS) and Angus Energy (ANGS).
Both bulls and bears appear to be taking something from the latest trading statement from Optibiotix (OPTI) – the bears are wrong and what we learned is great news for we shareholders. I have chatted to Steve O’Hara at length and, as a result, I more bullish than I have been in a good while...
In today;s bearcast I discuss Alpha Growth (ALGW), Advanced Oncotherapy (AVO) and Optibiotix (OPTI) as well as Spain, the latest crisis in the special place in hell that is the EU.
Another day and another hugely positive announcement from Optibiotix (OPTI) to delight we loyal shareholders. This news is from Japan.
Another week and another deal is announced by OptiBiotix Health plc (OPTI). This is a three year supply agreement with Biolat JSC covering the supply of its cholesterol and blood pressure reducing LPLDL® strain in Estonia, Latvia and Lithuania. It seems that in the Baltic states they are more likely to die of heart disease than anyone else on this planet so it is not a bad target market.
With the Sith Lord Zak Mirinterviewing him, Adam Reynolds had nothing to fear. But there were questions from the audience that were far more daunting and interesting than those posed by Britain's worst chartist.If you are, like me, a holder of Optibiotix (OPTI), Yourgene (TGEN) - my Q1 nap pick - Big Sofa (BST) - my tip of the year - or Conc epta (CPT) you will want to watch this. I have never been more bullish on the quartet. This will be our year and I know Adam feels the same. The next City forum hosted by the Sith Lord is February 25. Put the date in your diary now.
The regvular bearcast will appear later. In this podcast I cover Optibiotix (OPTI), Yourgene (YGEN), Wishbone (WSBN), Falanx (FLX), Concepta (CPT), Big Sofa (BST), Red Rock Resources (RRR), Reach4Entertainment (R4E), Obtala (OBT), Ariana (AAU), Wandisco (WAND), Fox Marble (FOX), Argo Blockchain (aaaaaaaaaaaaaaaaaaaaaaagh) and Kefi (KEFI)
The latest deal from Optibiotix (OPTI) is a three year distribution agreement with a company called SilvEXPO Ltd to distribute and commercialise OptiBiotix's own label CholBiome products containing its cholesterol and blood pressure reducing LPLDL strain in Russia and Kazakhstan...
OptiBiotix Health (OPTI) has announced that it has entered into an exclusive manufacturing and supply agreement with Zeon Lifesciences. The agreement grants Zeon an exclusive license to manufacture and supply OptiBiotix's SlimBiome weight management technology in India, in return for 50% of the profit...
In today's bearcast I bring you a hot rumour. The King of the spiv bucket shops Jon Bellis of Novum is apparently trying to raise £4 million at 10p for Anglo African Oil & Gas (AAOG). I look at Sound Energy (SOU), Andalas (ADL), delays in selling houses and in a similar vein what IFA's who have put clients into Woodford funds do next. I also look at Gear4Music (G4M) and director share buying which is a sell signal. I make a brief comment on Optibiotix (OPTI) and almost tie it in with a mother-in-law joke but resist the temptation.
I start with a report back on my torture of last night. Then I look at a day of woe for Neil Woodford, commenting on the Kier (KIE) debacle which has shown him at his arrogant and reckless worst. Then I ask questions about share trades announced late yesterday in BCA marketplace (BCA), I look at Sosandar (SOS), Optibiotix (OPTI), Bluebird Merchant Ventures (BMV), Yu (YU.) and at Avanti Comunications (AVN).
OptiBiotix Health (OPTI) has announced that its formerly wholly owned subsidiary ProBiotix Health Limited has raised £1.025 million of capital through the issue of convertible loan notes. So what you say?
In today's podcast I start with Deutsche Bank and the dire problems faced by the EU. Who really wants to stay in bed with this corpse? That pans out to wider reasons to be bearish and I cannot stress too much look not at P&Ls but at balance sheets. I look specifically today at Photonstar Led (PSL), Tomco (TOM), Low & Bonar (LWB), Argo Blockchain (Don't laugh at me too much), Optibiotix (OPTI), IQE (IQE) and the scandalous behaviour of team BlueJay Mining (JAY), moving on from the points flagged up HERE
Optibiotix (OPTI) boss Steve O’Hara has dusted down his Adam Reynolds keyboard for another RNS which the market seems, unwisely to ignore. But we, the faithful shareholders, will be rewarded for our patience with something far more stirring and we shouldn’t be waiting very long at all...
On Tuesday we learned how Optibiotix (OPTI) had secured medical device approval for Slimbiome and a CE Mark and that it had been working on this for two and a half years. We suggested that it would thus hit the ground running and so it was perfectly plausible that it could be delivering annualised profits of £7 million from this one product within two years. On Thursday we saw evidence of how well prepared it is for a rapid rollout.
Okay, I know that an interview with Proactive Investor is not exactly taxing, the questions make those posed by the Sith Lord Zak Mir look like the Spanish Inquisition in full flow. But Optibiotix (OPTI) has more great news today and Steve O' Hara rams that home in the video below. The shares are 96p and I am certainly not selling any at anywhere near this price - they are going a lot higher.
The olive harvest starts tomorrow and I will be assisted by a Shareprophets reader from Eire and by Andrew Bell of Red Rock Resources (RRR) who is trying to communicate with the natives in his best Ancient Greek. I expliain why today's output from me is limited and then break the latest news from Julie "lingerie on expenses" Meyer MBE. Then I look at Independent Oil & Gas (IOG), Optibiotix (OPTI), Dignity (DTY) and the scam that is the funeral industry and BCA marketplace (BCA) which may have hoodwinked Andrew Monk but whose interims today are shoking. They could have been written by wretched Theresa May and are alarmingly bad. I also comment on the Project Fear Brexit uber bollocks spouted by the not fit for purpose Bank of England Governor Mark Carney yesterday.
In today's podcast I look at Tomco (TOM), Watchstone (WTG), the bastard son of Quenron, Condor Gold (CNR), dire numbers from WH Ireland (WHI) and the read across to the FinnCrap IPO, Amedeo Resources (AMED), the Sith Lord Zak Mir and Optibiotix (OPTI) and at Haydale (HAYD)
“This is the second most important announcement we’ve made since we listed.” So said Optibiotix (OPTI) boss Steve O’Hara as we chatted this morning. The news is massive. Having worked on gaining medical device status and a CE Mark for the weight loss product Slimbiome for two and a half years, permission has finally been granted...
I am back at the Greek Hovel and the noise outside is quite unbelievably torrential rain. I discuss the weather and how stunning the Hovel now looks. Photos are starting to go up HERE on TomWinnifrith.com. I look at Optibiotix (OPTI) and today's stunning news. Cynical Bear needs to get ready to send me another bottle of ouzo. I look at Xeros (XSG), Thomas Cook (TCG) and Telit (TCM) where the clock is ticking ever louder. I have a few more words on the IPO of FinnCrap.
Shares in Optibiotix (OPTI) have not been immune to the general market sell off and trade at 64p-66p despite some more positive news. The frustration is that it has been announced with a release typed on the Adam Reynolds keyboard, the one with no numbers on it. But fear not bigger deals with real numbers will follow shortly...
Having reached circa 130p in August, shares in OptiBiotix Health (OPTI) have slid to 78p-81p. This is despite a pipeline of seemingly very significant deals likely to be converted and as such…
I am looking forward to grilling Premaitha (NIPT) at the Nigel Wray London seminar on 16 October. There are still a few places going and its free – details HERE. Meanwhile we have three pieces of news this week following that rather disappointing placing at 10p two Friday's ago caused by the a’hole behaviour of the toads at FinnCap. Yes this is Tom Winnifrith writing…
In today's bearcast I help my pal Mr Lenigas out and answer his question as to why shares in Angus (ANGS) are not rising after the Balcombe flow results yesterday. I look at Blue jay (JAY) where it is placing ahoy, Pantheon Resources (PANR), Optibiotix (OPTI) and in detail at Malcolm's favourite penny dreadful, Feedback (FDBK) and its risible trading statement today.
Some of you will be aware of my whining about market makers and house broker games played out on the trading floor of AIM. I am sure some of you think these are merely conspiracy theories of a blogger and attempted to explain negative share price movements on a particular day. I'm not going to rehash my market maker theory again, instead, lets discuss a the role of a house broker, I guess these creatures are right at the top of the tree, along with bankers, as a breed of creatures we hate because we feel they cannot be trusted, and yet we are effectively held to ransomed because of the duty they perform.
Come home to a real fire...buy a second home in Wales. You remember the sketch. Anyhow, the Mrs and i are looking and pondering because, as you know, she wants to pursue her career and I want to rear goats. The exercise, however, throws up very real questions about house prices. Moving on I look at Bushveld Minerals (BMN), Optibiotix (OPTI), Avanti Communications (AVN), Imaginatik (IMTK), Redhall (RHL) and Mitie (MTO) another company whose former boss helps to make Jeremy Corbyn's quite insane policies seem almost desirable.
The great success that was the 2018 UK Investor Show saw six 'Dragon's Den' sessions where a number of CEOs each gave a 1 minute (well, supposed to be!) pitch and three 'Dragons' at each session each picked a stock for a £1,000 investment. With the show having been on April 21st, here’s a monthly performance update...
In this podcast I discuss the anniversary, today's DOS attack and how I respond. I look at the terrifying proposals to steal your cash coming from the Labour conference and I discuss Optibiotix (OPTI), FastJet (FJET), BCA Marketplace (BCA), TrakM8 (TRAK) and the fraud Eden (EDEN). I also look at brokers such as FinnCap giving away free propaganda reports, I mean research, on corporate clients.
This series has gone on long enough so I’m bringing it to close this month with the biggest news relating to the ongoing moving of the goalposts at Kibo Energy (KIBO) which makes one wonder whether the flagship project in Tanzania is ever going to see the light of day.
I have had one of those days which happen all too often when I think I want to retire. Blame Laurence Smith. All is explained in this podcast. I look at today's news from Premaitha (NIPT) which is certainly a bolt from the blue, comment on the nature of corporate lying, ref Frontera (FRR), cover RM2 (RM2), Optibiotix (OPTI), Sosandar (SOS) and Online Blockchain (DOG).
The great success that was the 2018 UK Investor Show saw six 'Dragon's Den' sessions where a number of CEOs each gave a 1 minute (well, supposed to be!) pitch and three 'Dragons' at each session each picked a stock for a £1,000 investment. With the show having been in April, here’s a further monthly performance update...
Having top sliced our holdings in Optibiotix (OPTI) a few weeks ago I see the shares are back at 94p today despite it having served up cracking news last week. I am asked if I am panicked? Not at all. I fully expect the shares to bounce sharply on more good news. Are we buying more? No I stated clearly, I wanted to build up our cash reserves as I am worried about the market. That has not changed. Yesterday CEO Steve O'Hara did an interview with Proactive and if you are worried watch it, below, and you should be greatly reassured.
This was our August share tip of the month which came out last week: Having advised you to bank some gains on Optibiotix (OPTI) a couple of weeks ago at 131p we see that the shares are now just under 100p following results yesterday. We were sorely tempted to make this our tip of the month again as we are sure that there will be a stack of news in the coming weeks on some really big name deals ( with numbers!) and that we could have advised banking a quick 30% gain by mid October. You can hear Tom Winnifrith’s thoughts on Optibiotix in his Thursday bearcast HERE But that trade would have been a bit spivvy don’t you think? So instead…
I do not apologise for a second for advising folks to top slice Optibiotix (OPTI) at 131p but today the company has served up news which shows why it was right to hang onto at least part of your holding ( and we have held onto 6/7 of ours). Today’s release is big and does not use the Adam Reynolds keyboard – there are real numbers and big numbers.
I start with a rant about Barclays (BARC) banksters and how much I despise and loathe them. I then discuss Anglo African Agriculture (AAAP) a Big Dave Lenigas lobster pot from which I escaped today. I move onto Andalas (ADL) and have a challenge for a sad geek with time on his hands, I nominate Drunken Sailor. I look at Xaar (XAR), Crawshaw (CRAW) and finally at Optibiotix (OPTI). I owe cynical bear a glass of ouzo but drank it myself on his behalf. Warning, this podcast contains bad language throughout.
It’s that time of the month again and with two of the seven mythical creatures proving their existence so far, I was hoping for some more progress this month from the remaining five. Alas no, just more prevarication, distraction and fund raising – how disappointing.
The great success that was the 2018 UK Investor Show saw six 'Dragon's Den' sessions where a number of CEOs each gave a 1 minute (well, supposed to be!) pitch and three 'Dragons' at each session each picked a stock for a £1,000 investment. With the show having been on April 21st, how's the standings a third of the way through the competition?...
What looks like wallpaper in Mr Rehne's spare room really is ghastly and I am not sure what a director of Optibiotix (OPTI) is doing recording a webcast with investment hookers Proactive, a week or so before results day, but whatever, what do I know. Per seems in upbeat mood. For the record, having followed our own advice and top slice ( selling c 1/6) of our holding at 125p, we are not selling any more at the current 108p-111p.
In today's delayed podcast I look at the lessons for SalvaRx (SALV) from the Plethora (PLE) & Regent Pacific episode and ask what is happening at Regent as its shares continue to slide? I also look at the increasingly confused picture at Online Blockchain (OBC) and then ponder why CEO's should not be a guide to share prices or when to sell, ref Optibiotx (OPTI), noting also today's events at Skinbiotherapeutics (SBTX)